Patent Assignment
Reel/Frame 021027/0070
Assignment of Assignor's Interest
Recorded: 2008-06-02
Pages: 7
Assignors
BARBERIS, ALCIDE
Executed: 2008-01-18
URECH, DAVID M.
Executed: 2008-01-18
LICHTLEN, PETER
Executed: 2008-01-18
AUF DER MAUR, ADRIAN
Executed: 2008-01-18
EWERT, STEFAN
Executed: 2008-01-21
Assignee
ESBATECH AG
WAGISTRASSE 21, SCHLIEREN, CH-8952, SWITZERLAND
Covered Property
(1)
Stable and Soluble Antibodies Inhibiting Tnf Alpha
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Dec 11, 2009
From: ESBATECH AG
To: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT GMBH
Reel/Frame 023639/0314 →
Corrective Assignment to Correct the Legal Status of the Assignee as Llc, Not Gmbh Previously Recorded on Reel 023639 Frame 0314. Assignor(S) Hereby Confirms the Legal Status of the Assignee Is Esbatech, an Alcon Biomedical Research Unit Llc.
Jan 4, 2010
From: ESBATECH AG
To: ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT LLC
Reel/Frame 023720/0976 →
Assignment of Assignor's Interest
Aug 23, 2018
From: ESBATECH, A NOVARTIS COMPANY LLC
To: CELL MEDICA SWITZERLAND AG
Reel/Frame 046677/0476 →
Assignment of Assignor's Interest
Jan 21, 2021
From: CELL MEDICA SWITZERLAND AG
To: CELL MEDICA INC.
Reel/Frame 054988/0114 →
Security Interest
Jul 7, 2021
From: CELL MEDICA, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 056782/0954 →
Assignment of Assignor's Interest
Jul 18, 2022
From: CELL MEDICA INC.
To: CELL MEDICA, INC.
Reel/Frame 060529/0195 →